Crinetics Pharmaceuticals (CRNX) Profit After Tax (2017 - 2026)
Crinetics Pharmaceuticals' quarterly Profit After Tax came in at -$127.8 million in Q1 2026, down 32.11% year-on-year from -$188.3 million in Q1 2025, and down 4.1% quarter-over-quarter from -$122.8 million in Q4 2025.
Crinetics Pharmaceuticals has reported Profit After Tax for 10 years, with the latest figure at -$127.8 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 32.11% year-over-year to -$127.8 million; the trailing twelve-month figure through Mar 2026 stood at -$496.4 million (down 51.22% YoY), and the FY2025 full-year result was -$465.3 million, down 55.93% from the prior year.
- Profit After Tax for Q1 2026 stood at -$127.8 million, down from -$122.8 million in the prior quarter.
- The five-year high for Profit After Tax was -$34.6 million in Q1 2022, with the low at -$130.1 million in Q3 2025.
- Average Profit After Tax over 5 years is -$74.7 million, with a median of -$66.9 million recorded in 2024.
- Year-over-year, Profit After Tax fell 20.3% in 2023 and plunged 69.33% in 2025.
- Tracing CRNX's Profit After Tax over 5 years: stood at -$45.0 million in 2022, then tumbled by 33.58% to -$60.1 million in 2023, then sank by 34.11% to -$80.6 million in 2024, then plunged by 52.39% to -$122.8 million in 2025, then decreased by 4.1% to -$127.8 million in 2026.
- The last three Profit After Tax figures came in at -$127.8 million (Q1 2026), -$122.8 million (Q4 2025), and -$130.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn | -127.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -127.85 Mn |
| Dec 31, 2025 | -122.82 Mn |
| Sep 30, 2025 | -130.09 Mn |
| Jun 30, 2025 | -115.64 Mn |
| Mar 31, 2025 | -96.77 Mn |
| Dec 31, 2024 | -80.60 Mn |
| Sep 30, 2024 | -76.83 Mn |
| Jun 30, 2024 | -74.06 Mn |
| Mar 31, 2024 | -66.93 Mn |
| Dec 31, 2023 | -60.10 Mn |
| Sep 30, 2023 | -57.46 Mn |
| Jun 30, 2023 | -50.98 Mn |
| Mar 31, 2023 | -46.00 Mn |
| Dec 31, 2022 | -44.99 Mn |
| Sep 30, 2022 | -41.93 Mn |
| Jun 30, 2022 | -42.38 Mn |
| Mar 31, 2022 | -34.63 Mn |
| Dec 31, 2021 | -30.79 Mn |
| Sep 30, 2021 | -27.85 Mn |
| Jun 30, 2021 | -26.10 Mn |
| Mar 31, 2021 | -22.90 Mn |
| Dec 31, 2020 | -21.64 Mn |
| Sep 30, 2020 | -18.32 Mn |
| Jun 30, 2020 | -16.49 Mn |
| Mar 31, 2020 | -17.36 Mn |
| Dec 31, 2019 | -14.55 Mn |
| Sep 30, 2019 | -14.43 Mn |
| Jun 30, 2019 | -12.43 Mn |
| Mar 31, 2019 | -9.02 Mn |
| Dec 31, 2018 | -8.50 Mn |
| Sep 30, 2018 | -7.59 Mn |
| Jun 30, 2018 | -5.57 Mn |
| Mar 31, 2018 | -5.46 Mn |
| Dec 31, 2017 | -2.52 Mn |
| Sep 30, 2017 | -2.38 Mn |
| Jun 30, 2017 | -1.65 Mn |